Reported Dec 7, 2016 · Terminated

Hyolev MB URINARY ANTISEPTIC Tablets, Each tablet for oral administration contains: Hyoscyamine Sulfate 0.12 mg,…

Burel Pharmaceuticals Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Burel Pharmaceuticals Inc · 199 Interstate Dr Ste N · Richland, MS · 39218-9433

Is this the product you have?

  • Hyolev MB URINARY ANTISEPTIC Tablets, Each
  • tablet for oral administration contains
    • Hyoscyamine Sulfate 0.12 mg
    • Methenamine 81 mg
    • Methylene Blue 10.8 mg
    • Phenyl Salicylate 32.4 mg
    • Sodium Phosphate Monobasic 40.8 mg
    • 90 count bottles
    • Rx only
  • Manufactured forBUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-301-90
Lot codes and dates
    • LOT # 29001501
    • EXP 07/17
Amount recalled
2861 bottles

This recall covers 8 products

The agency filed one notice per product. You are reading one of them; the other 7 are below.

Where it was sold

  • Nationwide

Why it was recalled

CGMP Deviations; deficiencies at the manufacturer may result in assay or content uniformity failures

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Burel Pharmaceuticals Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 14, 2017 · Data as of Sep 19, 7:13 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.